Fabry disease
Copyright policy )Fabry disease
Fabry disease is an inherited enzyme deficiency of galactosidase A that results in various phenotypes: classic, cardiac or renal. It can present variably and may represent an important cause of occult neurological and cardiac syndromes and renal failure. Preclinical and clinical studies demonstrate effectiveness of enzyme infusion in controlling and preventing these manifestations of the disease.
Male, alpha-Galactosidase, Drug Evaluation, Preclinical, Animals, Fabry Disease, Humans, Infusions, Intravenous, Drug Approval, Drug Administration Schedule, Recombinant Proteins, Randomized Controlled Trials as Topic
Male, alpha-Galactosidase, Drug Evaluation, Preclinical, Animals, Fabry Disease, Humans, Infusions, Intravenous, Drug Approval, Drug Administration Schedule, Recombinant Proteins, Randomized Controlled Trials as Topic
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).3 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!